Home/Beroni Group/Katsuo Noguchi
KN

Katsuo Noguchi

Chief Scientist (Japan)

Beroni Group

Beroni Group Pipeline

DrugIndicationPhase
PENAOSolid Tumors (ovarian, breast, pancreatic)Preclinical
Immune Cell Therapy PlatformCancer & Age‑related DegenerationPreclinical
SARS‑CoV‑2 Antigen Test KitInfectious Disease DiagnosisCommercial (CE‑certified)